KRC - Retail Research

SELL GLENMARK AT Rs 340

Long Term Investors can still hold the position in Glenmark Pharma with a target price of Rs. 390


Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd